Back to search

University of South Florida

Development of Bioactive Peptidomimetics

Abstract

dc:description

In the past two decades, a lot of different peptidomimetics, such as β-peptides, oligoureas, azapeptides, peptoids, aromatic oligoamides, and others, have been developed. These peptidomimetics with distinctive scaffolds have shown potential in protein surface recognition and mimicry, PPI regulation, catalysis, etc. Moreover, these bioactive peptidomimetics demonstrate much better bioavailability and biostability than the bioactive peptides. To expand the application of peptidomimetics, our group have developed a new sequence-specific peptidomimetics- γ-AApeptide, which is derived from chiral γ-PNA. It shows excellent advantages including highly resistant to various proteolytical degradations and has the potential to increase chemodiversity. γ-AApeptide also exhibits remarkable biomedical applications, such as antibacterial, anti-cancer and anti-Alzheimer’s development. However, it has never been reported before to use γ-AApeptide scaffold to design inhibitors to prevent virus infection. Especially, COVID-19 is a pandemic that has a serious impact on global health right now. In this work, we were trying to apply the γ-AApeptide based foldamers to three different projects. Firstly, we have reported the design and synthesis of constrained α, γ-AApeptide, which served as the scaffold to design aldehydes and ketoamides to bind Mpro of the SARS-CoV-2. Secondly, Macrocyclic γ-AApeptides combinational library was used to screen against the HR1 domain of the S2 subunit of the SARS-CoV-2 virus. As such, we found a potential macrocyclic γ-AApeptides potently inhibited SARS-CoV-2 infection. Thirdly, we also applied a combinational library of macrocyclic γ-AApeptides to the target, GpsB, a specific target of Gram-positive bacteria, which allowed us to identify a possible antibiotic. All the findings in my dissertation revealed a new application of the γ-AApeptides, especially in the development to combat the viral pandemic and bacterial infection. These findings also emphasize the relationship between structure and function of γ-AApeptides and highlight γ-AApeptides as an alternative paradigm for future PPI modulation.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry
Grantor
University of South Florida
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wang, Lei
Contributors dc:contributor
  • Jianfeng J. Cai, Ph.D.
  • Wayne Guida, Ph.D.
  • Cheng Feng, Ph.D.
  • Kirpal Bisht, Ph.D.

Subjects

dc:subject × 7

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10774

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Wang, Lei. Development of Bioactive Peptidomimetics. Dissertation thesis, University of South Florida, 2023. https://digitalcommons.usf.edu/etd/10774